The Management of Erythrodermic Psoriasis Complicated by Cyclosporine

We present a 64-year-old woman with past medical history of psoriasis and alcoholic liver cirrhosis who presented with a diffuse, erythematous, and scaly rash. Pertinent medications included topical triamcinolone 0.1% cream. She was started on oral prednisone 40 milligrams (mg) and oral cyclosporine...

Full description

Saved in:
Bibliographic Details
Main Authors: Suman Rao, Michelle Bernshteyn, Raman Sohal, Rachael Proumen, Alexandra Goodman, Zachary Shepherd
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Case Reports in Dermatological Medicine
Online Access:http://dx.doi.org/10.1155/2020/5215478
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849434793394044928
author Suman Rao
Michelle Bernshteyn
Raman Sohal
Rachael Proumen
Alexandra Goodman
Zachary Shepherd
author_facet Suman Rao
Michelle Bernshteyn
Raman Sohal
Rachael Proumen
Alexandra Goodman
Zachary Shepherd
author_sort Suman Rao
collection DOAJ
description We present a 64-year-old woman with past medical history of psoriasis and alcoholic liver cirrhosis who presented with a diffuse, erythematous, and scaly rash. Pertinent medications included topical triamcinolone 0.1% cream. She was started on oral prednisone 40 milligrams (mg) and oral cyclosporine 150 mg daily and was continued on topical triamcinolone. After the administration of two doses of this regimen, the serum creatinine increased to 1.76 mg/dL, and serum potassium increased to 6.7 mEq/L. The serum creatinine continued to uptrend to 2.42 mg/dL, and the glomerular filtration rate (GFR) decreased to 20 mL/min. The patient was emergently hemodialyzed. The patient was placed on an extended steroid taper, alleviating the psoriatic rash. However, the patient needed to be placed on a steroid-sparing regimen. Because of its rarity and ensuing complications, erythrodermic psoriasis must be identified and managed promptly. Cyclosporine is currently the first-line treatment. However, initiation of this therapy in our patient resulted in an acute kidney injury (AKI). Even though a steroid taper assisted in alleviating erythroderma, a steroid-sparing regimen needed to be started. This led to the consideration of alternate methods of therapy for further management of erythrodermic psoriasis with renal impairment.
format Article
id doaj-art-e3b910deeedf401d83a491b40331036c
institution Kabale University
issn 2090-6463
2090-6471
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Case Reports in Dermatological Medicine
spelling doaj-art-e3b910deeedf401d83a491b40331036c2025-08-20T03:26:31ZengWileyCase Reports in Dermatological Medicine2090-64632090-64712020-01-01202010.1155/2020/52154785215478The Management of Erythrodermic Psoriasis Complicated by CyclosporineSuman Rao0Michelle Bernshteyn1Raman Sohal2Rachael Proumen3Alexandra Goodman4Zachary Shepherd5SUNY Upstate Medical University Hospital, 750 E Adams St., Syracuse, NY 13210, USASUNY Upstate Medical University Hospital, 750 E Adams St., Syracuse, NY 13210, USASUNY Upstate Medical University Hospital, 750 E Adams St., Syracuse, NY 13210, USASUNY Upstate Medical University Hospital, 750 E Adams St., Syracuse, NY 13210, USASUNY Upstate Medical University Hospital, 750 E Adams St., Syracuse, NY 13210, USASUNY Upstate Medical University Hospital, 750 E Adams St., Syracuse, NY 13210, USAWe present a 64-year-old woman with past medical history of psoriasis and alcoholic liver cirrhosis who presented with a diffuse, erythematous, and scaly rash. Pertinent medications included topical triamcinolone 0.1% cream. She was started on oral prednisone 40 milligrams (mg) and oral cyclosporine 150 mg daily and was continued on topical triamcinolone. After the administration of two doses of this regimen, the serum creatinine increased to 1.76 mg/dL, and serum potassium increased to 6.7 mEq/L. The serum creatinine continued to uptrend to 2.42 mg/dL, and the glomerular filtration rate (GFR) decreased to 20 mL/min. The patient was emergently hemodialyzed. The patient was placed on an extended steroid taper, alleviating the psoriatic rash. However, the patient needed to be placed on a steroid-sparing regimen. Because of its rarity and ensuing complications, erythrodermic psoriasis must be identified and managed promptly. Cyclosporine is currently the first-line treatment. However, initiation of this therapy in our patient resulted in an acute kidney injury (AKI). Even though a steroid taper assisted in alleviating erythroderma, a steroid-sparing regimen needed to be started. This led to the consideration of alternate methods of therapy for further management of erythrodermic psoriasis with renal impairment.http://dx.doi.org/10.1155/2020/5215478
spellingShingle Suman Rao
Michelle Bernshteyn
Raman Sohal
Rachael Proumen
Alexandra Goodman
Zachary Shepherd
The Management of Erythrodermic Psoriasis Complicated by Cyclosporine
Case Reports in Dermatological Medicine
title The Management of Erythrodermic Psoriasis Complicated by Cyclosporine
title_full The Management of Erythrodermic Psoriasis Complicated by Cyclosporine
title_fullStr The Management of Erythrodermic Psoriasis Complicated by Cyclosporine
title_full_unstemmed The Management of Erythrodermic Psoriasis Complicated by Cyclosporine
title_short The Management of Erythrodermic Psoriasis Complicated by Cyclosporine
title_sort management of erythrodermic psoriasis complicated by cyclosporine
url http://dx.doi.org/10.1155/2020/5215478
work_keys_str_mv AT sumanrao themanagementoferythrodermicpsoriasiscomplicatedbycyclosporine
AT michellebernshteyn themanagementoferythrodermicpsoriasiscomplicatedbycyclosporine
AT ramansohal themanagementoferythrodermicpsoriasiscomplicatedbycyclosporine
AT rachaelproumen themanagementoferythrodermicpsoriasiscomplicatedbycyclosporine
AT alexandragoodman themanagementoferythrodermicpsoriasiscomplicatedbycyclosporine
AT zacharyshepherd themanagementoferythrodermicpsoriasiscomplicatedbycyclosporine
AT sumanrao managementoferythrodermicpsoriasiscomplicatedbycyclosporine
AT michellebernshteyn managementoferythrodermicpsoriasiscomplicatedbycyclosporine
AT ramansohal managementoferythrodermicpsoriasiscomplicatedbycyclosporine
AT rachaelproumen managementoferythrodermicpsoriasiscomplicatedbycyclosporine
AT alexandragoodman managementoferythrodermicpsoriasiscomplicatedbycyclosporine
AT zacharyshepherd managementoferythrodermicpsoriasiscomplicatedbycyclosporine